Pricing Log in Create free account

Equillium, Inc. (EQ) vs Seer, Inc. (SEER)

Equillium, Inc. and Seer, Inc. are both Biotechnology companies. Equillium, Inc. and Seer, Inc. are of similar size ($92.3M and $89.1M). Equillium, Inc. grew revenue faster over the last twelve months: 13.9% against −14.0%. Equillium, Inc. has the higher net margin (0.00% vs −450.9%) and the higher return on invested capital (0.00% vs −72.5%). Across the 16 metrics below, Equillium, Inc. leads on 11 and Seer, Inc. on 5.

Valuation

Metric EQ SEER Biotechnology median
P/E n/m n/m 10.96
P/S 4.00 6.27 9.52
P/B 2.93 0.41 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m 1.06 0.68
EV/Sales 2.79 (4.80) 9.00
Earnings yield (13.61%) (76.25%) (32.09%)
Free cash flow yield (12.22%) (52.06%) (22.62%)

Profitability

Metric EQ SEER Biotechnology median
Gross margin 100.00% 46.53% 68.51%
Operating margin 0.00% (469.91%) 0.00%
Net margin 0.00% (450.86%) 0.00%
Free cash flow margin 0.00% (326.40%) 0.00%
Return on equity (58.98%) (26.19%) (50.12%)
Return on assets (50.68%) (23.06%) (45.12%)
Return on invested capital 0.00% (72.54%) 0.00%

Growth

Metric EQ SEER Biotechnology median
Revenue growth (TTM) 13.89% (14.04%) 6.78%
EPS growth (last fiscal year) (69.57%) 7.91% 29.88%
Revenue growth, 5-year CAGR — 90.78% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EQ SEER Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 23.40 16.89 4.74
Net debt to EBITDA 1.29 2.63 1.01

Dividend

Metric EQ SEER Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric EQ SEER Biotechnology median
Market cap 92.26m 89.14m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack